ARCHIVES

House Members Urge FDA to Review Fast Track Policies

This article is from The Cancer Letter archive.

Vol. 28 No. 27 | July 5, 2002

Download PDF Visit The Full Archive

Related Articles

With $1.1 Billion At Stake, Cancer Groups Mull Comparative Effectiveness Studies

May 22, 2009

NCI Communications Director Sieber To Retire; Science Planner Waldrop Also To Leave NCI.

September 14, 2001

Starr Foundation Gives $100 Million To Form Cancer Consortium.

September 29, 2006

Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment

February 7, 2014

Waldmann, Columbia, Netherland, Receive Bristol-Myers Awards

April 17, 1992

DCT Programs Status Reported to Board

July 5, 1985